Sharon Chase is a seasoned finance leader with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Senior Director and Head of Finance for Rare Disease at Ipsen since April 2025, Sharon is a strategic advisor focused on aligning financial strategies with business goals. Prior roles include Senior Director of Financial Planning and Analysis at Metabolon, Inc., and significant contributions at Biogen, Takeda, EMD Serono, Medtronic, and Haemonetics in various senior finance capacities, where Sharon drove operational excellence, financial management, and strategic decision-making. Sharon holds a Bachelor of Arts with Honors in Accounting and Finance from Lancaster University and an Advanced Level GCE in Accounting, Economics, and Statistics from Mara Science College.
This person is not in any teams
This person is not in any offices